HEALIUS LIMITED — Director's Dealing 2023

Feb 27, 2023

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity	HEALIUS LIMITED
ABN	24 064 530 516

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director	Jennifer Macdonald
Date of last notice	28 September 2022

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest	Direct
Nature of indirect interest
(including registered holder)	N/A
Note: Provide details of the circumstances giving
rise to the relevant interest.
Date of change	28 February 2023
	12,048 Ordinary Shares*	Jennifer Macdonald
No. of securities held prior to	70,000 Ordinary Shares	Jennifer Macdonald
change	* Shares are subject to a holding	lock as “Restricted Securities”
	under the NED Share Plan.
Class	Fully paid Ordinary Shares
Number acquired	37,500
Number disposed	N/A
Value/Consideration
Note: If consideration is non-cash, provide details	$2.7510 per share
and estimated valuation

• See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

	12,048 Ordinary Shares*	Jennifer Macdonald
No. of securities held after	107,500 Ordinary Shares	Jennifer Macdonald
change	* Shares are subject to a holding	lock as “Restricted Securities”
	under the NED Share Plan.
Nature of change
Example: on-market trade, off-market trade,exercise of options, issue of securities under	On-market trade
dividend reinvestment plan, participation in buy-
back

Part 2 – Change of director’s interests in contracts Not applicable

Part 3 –[+] Closed period

Were the interests in the securities or contracts detailed above traded during a[+] closed period where prior written N/A clearance was required? If so, was prior written clearance provided to allow the N/A trade to proceed during this period? If prior written clearance was provided, on what date was N/A this provided?

Authorised by the Company Secretary.

Charles Tilley Company Secretary Date: 28 February 2023

• See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011